These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1166 related articles for article (PubMed ID: 30685261)
1. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis. Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261 [TBL] [Abstract][Full Text] [Related]
2. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis. Lu X; Lin J BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study. Yhim HY; Lee J; Lee JY; Lee JO; Bang SM PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415 [TBL] [Abstract][Full Text] [Related]
4. Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis. Neumann I; Rada G; Claro JC; Carrasco-Labra A; Thorlund K; Akl EA; Bates SM; Guyatt GH Ann Intern Med; 2012 May; 156(10):710-9. PubMed ID: 22412038 [TBL] [Abstract][Full Text] [Related]
5. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair. Forster R; Stewart M Cochrane Database Syst Rev; 2016 Mar; 3(3):CD004179. PubMed ID: 27027384 [TBL] [Abstract][Full Text] [Related]
6. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials. Ma G; Zhang R; Wu X; Wang D; Ying K Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496 [TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review. Adam SS; McDuffie JR; Lachiewicz PF; Ortel TL; Williams JW Ann Intern Med; 2013 Aug; 159(4):275-84. PubMed ID: 24026260 [TBL] [Abstract][Full Text] [Related]
9. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539 [TBL] [Abstract][Full Text] [Related]
10. Safety and effectiveness of aspirin and enoxaparin for venous thromboembolism prophylaxis after total hip and knee arthroplasty: a systematic review. Nadi S; Vreugdenburg TD; Atukorale Y; Ma N; Maddern G; Rovers M ANZ J Surg; 2019 Oct; 89(10):1204-1210. PubMed ID: 30989803 [TBL] [Abstract][Full Text] [Related]
11. Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials. Ning GZ; Kan SL; Chen LX; Shangguan L; Feng SQ; Zhou Y Sci Rep; 2016 Mar; 6():23726. PubMed ID: 27020475 [TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty. Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095 [TBL] [Abstract][Full Text] [Related]
13. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis. Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711 [TBL] [Abstract][Full Text] [Related]
14. Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty. Levitan B; Yuan Z; Turpie AG; Friedman RJ; Homering M; Berlin JA; Berkowitz SD; Weinstein RB; DiBattiste PM Vasc Health Risk Manag; 2014; 10():157-67. PubMed ID: 24707185 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis. Liu J; Zhao J; Yan Y; Su J Medicine (Baltimore); 2019 Mar; 98(9):e14539. PubMed ID: 30817570 [TBL] [Abstract][Full Text] [Related]
16. Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis. Kapoor A; Ellis A; Shaffer N; Gurwitz J; Chandramohan A; Saulino J; Ishak A; Okubanjo T; Michota F; Hylek E; Trikalinos TA J Thromb Haemost; 2017 Feb; 15(2):284-294. PubMed ID: 28102615 [TBL] [Abstract][Full Text] [Related]
17. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty. Wilson DG; Poole WE; Chauhan SK; Rogers BA Bone Joint J; 2016 Aug; 98-B(8):1056-61. PubMed ID: 27482017 [TBL] [Abstract][Full Text] [Related]
18. Venous thromboprophylaxis after total hip arthroplasty: aspirin, warfarin, enoxaparin, or factor Xa inhibitors? Bala A; Murasko MJ; Burk DR; Huddleston JI; Goodman SB; Maloney WJ; Amanatullah DF Hip Int; 2020 Sep; 30(5):564-571. PubMed ID: 30990095 [TBL] [Abstract][Full Text] [Related]
19. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: a systematic review. Januel JM; Chen G; Ruffieux C; Quan H; Douketis JD; Crowther MA; Colin C; Ghali WA; Burnand B; JAMA; 2012 Jan; 307(3):294-303. PubMed ID: 22253396 [TBL] [Abstract][Full Text] [Related]
20. Apixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single-centre, single-surgeon, retrospective analysis. King DA; Pow RE; Dickison DM; Vale PR Intern Med J; 2016 Sep; 46(9):1030-7. PubMed ID: 27246450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]